Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Reus
Clinical trial register · Spain

Clinical Trials in Reus, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Reus

47 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Fundacion Dexeus
Phase 4
154
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-10-15
Recruiting
Walnuts for Cardiorenal Protection in Adults With Chronic Kidney Disease
NCT07851454CKD - Chronic Kidney Disease, Renal Function, Cardiovascular Biomarkers
Institut Investigacio Sanitaria Pere Virgili
Not applicable
150
Reus
2026-08-04
Recruiting
Effects of Dry Needling on Latent Myofascial Trigger Points of the Extensor Digitorum Communis
NCT07672093Dry Needling Technique, Trigger Point Pain, Physical Therapy
University Rovira i Virgili
Not applicable
150
Reus
2026-07-01
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Santiago Compostela, Seville, Badalona, L'Hospitalet de Llobregat, Santander, Cáceres, Reus, A Coruña
2026-05-11
Recruiting
AI-TOP Study Artificial Intelligence for Trigger Optimization.
NCT07515118Infertility, Ovarian Stimulation, Artificial Intelligence
Fundacion Dexeus
Not applicable
644
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-04-08
Recruiting
Francisco Algaba Chueca
Observational
40
Reus, Tarragona
2026-04
Recruiting
Institut Investigacio Sanitaria Pere Virgili
Not applicable
60
Reus
2026-02-16
Not yet open
University Rovira i Virgili
Not applicable
70
Reus
2026-02-09
Active, closed
Action Observation and Exercise for Balance in Older Adults: A Randomized Trial.
NCT07199790Balance Disorders, Fall, Elderly (People Aged 65 or More), Exercise
University Rovira i Virgili
Not applicable
93
Reus
2026-02-01
Recruiting
Fundacion Dexeus
Phase 4
62
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-01-19
Recruiting
Avocado Consumption and Cellular Aging in Breast Cancer Survivors
NCT07097155Telomere Length, Breast Cancer Females
Institut Investigacio Sanitaria Pere Virgili
Not applicable
120
Reus
2026-01-12
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Barcelona, Madrid, Mataró, Málaga, Reus
2025-11-28
Recruiting
Effect of Agar/Collagen-based Compounds on Osteoarticular Pain: Randomized Triple-blind Clinical Trial
NCT07318896Osteearthritis, Joint Damage, Inflammation, Cartilage Damage
Fundació Eurecat
Not applicable
80
Reus
2025-11-10
Active, closed
Institut Investigacio Sanitaria Pere Virgili
Observational
1,000,000
Reus
2025-10-01
Recruiting
Fundació Eurecat
Not applicable
14
Reus
2025-08-01
Recruiting
Hoffmann-La Roche
Observational
700
Almería, Palma de Mallorca, Manresa, Puerto Real, Alcázar de San Juan, Santiago de Compostela, Oviedo, Reus
2025-07-15
Recruiting
MedSIR
Phase 2
20
Elche, Barcelona, Girona, Madrid, Reus, Alicante, Barakaldo, León
2025-06-27
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
AstraZeneca
Phase 3
473
A Coruña, Barcelona, Córdoba, Reus, Seville
2025-06-10
Recruiting
Effectiveness of an Online Biopsychosocial Intervention to Improve Well-being and Mental Health During Pregnancy
NCT06871397Prenatal Anxiety, Prenatal Depression, Wellbeing, Obstetrical Complications
University Rovira i Virgili
Not applicable
228
Reus
2025-04-03
Recruiting
Dietary Strategy to Tackle Cognitive and Locomotor Abilities in Early Elderly Subjects
NCT06871384Cognitive Disorders, Muscular Disorders, Atrophic
University Rovira i Virgili
Not applicable
72
Logroño, Reus
2025-03-26
Not yet open
Institut Investigacio Sanitaria Pere Virgili
Phase 4
122
Badalona, Barcelona, Reus, Santiago de Compostela
2024-12-10
Recruiting
Effect of a Grape Seed Proanthocyanidin Extract (GSPE) on LDL Cholesterol Levels in Rotating Night Shift Workers
NCT06422741Cardiovascular Diseases, Circadian Rhythm Sleep Disorder, Shift Work Type, Cholesterol Level, High
Fundació Eurecat
Not applicable
22
Reus
2024-10-28
Recruiting
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT06446882HER2-positive Breast Cancer, Early-stage Breast Cancer
Fundacio Clinic Barcelona
Not applicable
304
L'Hospitalet de Llobregat, Granada, Santiago de Compostela, León, Madrid, Murcia, Reus, Bilbao
2024-10-11
Recruiting
SOLTI Breast Cancer Research Group
Phase 2
50
Badalona, L'Hospitalet de Llobregat, Barcelona, Granada, Madrid, Reus, Seville, Valencia
2024-03-15
By invitation
Fundació Eurecat
Not applicable
480
Reus
2023-11-01
Recruiting
Fundació Eurecat
Not applicable
54
Reus
2023-09-09
Recruiting
Eli Lilly and Company
Phase 1/2
880
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Seville
2023-04-17
Active, closed
AlgoTherapeutix
Phase 2
276
Barcelona, Córdoba, Jaén, Madrid, Reus, Valencia
2023-02-28
Recruiting
The Impact of Radiotherapy on Oligometastatic Cancer
NCT05933876Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer, Metastatic Colorectal Cancer
Institut Investigacio Sanitaria Pere Virgili
Observational
2,000
Albacete, Barcelona, Granada, Lleida, Madrid, Seville, Reus, Valencia
2022-12-01
Active, closed
Gilead Sciences
Phase 3
1,021
Barcelona, Córdoba, Girona, Jaén, Las Palmas de Gran Canaria, Madrid, Majadahonda, Reus
2022-10-12
Recruiting
AstraZeneca
Phase 2
630
A Coruña, Alicante, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Reus
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
368
A Coruña, Palma, Barcelona, El Palmar, Málaga, Pamplona, Reus, Valencia
2022-03-11
Active, closed
MedSIR
Phase 2
393
L'Hospitalet de Llobregat, Córdoba, Reus, A Coruña, Alicante, Badalona, Barcelona, Bilbao
2021-08-05
Active, closed
Goat Infant Formula Feeding and Eczema (the GIraFFE Study)
NCT04599946Dermatitis, Atopic, Eczema, Infantile, Infant Development, Child Development
Dairy Goat Co-operative (N.Z.) Limited
Not applicable
2,132
Almería, Granada, Madrid, Reus, Tarragona, Valencia, Zaragoza
2021-01-08
Active, closed
Daiichi Sankyo
Phase 3
1,600
Bilbao, El Palmar, Reus, A Coruña, Alcorcón, Alicante, Badajoz, Barcelona
2020-12-04
Active, closed
Pfizer
Phase 3
1,068
Badalona, Granollers, L'Hospitalet de Llobregat, Majadahonda, Pamplona, Reus, A Coruña, Barcelona
2019-12-30
Active, closed
Spanish Oncology Genito-Urinary Group
Phase 2
39
Manresa, Sabadell, Reus, Granada, Lugo, Madrid, Ourense, Oviedo
2019-09-18
Recruiting
Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile
NCT06452745Colorectal Cancer, Colorectal Adenoma, Colorectal Polyp, Healthy
Institut Investigacio Sanitaria Pere Virgili
Observational
2,000
Reus, Tarragona
2019-07-20
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
366
Barcelona, Lleida, Madrid, Reus, Seville, Valencia
2019-06-14
Active, closed
MedSIR
Phase 2
377
Badalona, L'Hospitalet de Llobregat, Castelló, Jaén, Málaga, Reus, A Coruña, Barcelona
2017-06-26
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Barakaldo, Barcelona, Castellon, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Reus
2015-11-19
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Santiago de Compostela, Barakaldo, Logroño, Burela de Cabo, Málaga, Oviedo, Reus, A Coruña
2013-05-30
Recruiting
Early Detection of Familial Hypercholesterolemia in Children
NCT04370899Familial Hypercholesterolemia, Familial Hypercholesterolemia - Heterozygous, Familial Hypercholesterolemia - Homozygous
Institut Investigacio Sanitaria Pere Virgili
Observational
400
Reus
2013-03-14
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Barcelona, Bilbao, Reus, Valencia
2008-12-09
Recruiting
Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease
NCT05554224NAFLD, Obesity, Morbid, Comorbidities and Coexisting Conditions
Institut Investigacio Sanitaria Pere Virgili
Observational
1,104
Reus
2008-06-25
Rows per page Showing 1–47 of 47
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/reus

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 47 of those studies with a site in Reus.

How many clinical trials are recruiting in Reus?

28 of the 47 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 14 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Reus), 47 studies
PhaseStudiesRecruitingShare
Not applicable171236.2%
Observational9819.1%
Phase 29419.1%
Phase 38217%
Phase 4316.4%
Phase 1/2112.1%

Most active sponsors

Lead sponsors with the most studies (Reus)
Lead sponsorStudiesRecruiting
Institut Investigacio Sanitaria Pere Virgili97
University Rovira i Virgili63
Fundació Eurecat54
AstraZeneca32
Eli Lilly and Company32
Fundacion Dexeus32
MedSIR31
Alexion Pharmaceuticals, Inc.11
AlgoTherapeutix10
Aragon Pharmaceuticals, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.